Michael R Bishop Selected Research

Therapeutics

2/2024	CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists.
12/2023	Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome.
1/2023	Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
1/2023	Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
1/2023	Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
1/2023	Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
1/2023	Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
1/2023	Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.
10/2022	Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas.
1/2022	Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael R Bishop Research Topics

Disease

45	Neoplasms (Cancer) 02/2024 - 04/2003
16	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 03/2004
16	Lymphoma (Lymphomas) 09/2023 - 03/2003
14	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 03/2003
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2024 - 11/2012
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2024 - 08/2005
9	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2019
7	Cytokine Release Syndrome 12/2023 - 03/2004
7	Leukemia 01/2018 - 02/2004
7	Breast Neoplasms (Breast Cancer) 08/2009 - 01/2002
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2020
6	Multiple Myeloma 01/2023 - 06/2011
5	Residual Neoplasm 01/2012 - 06/2005
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 08/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2006
3	Bronchiolitis Obliterans Syndrome 04/2024 - 04/2005
3	Infections 10/2020 - 02/2007
3	Hodgkin Disease (Hodgkin's Disease) 02/2017 - 10/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2024 - 12/2013
2	Tumor Lysis Syndrome 11/2023 - 12/2013
2	cell-associated neurotoxicity 10/2022 - 12/2020
2	Disease Progression 10/2021 - 01/2019
2	Pathologic Complete Response 01/2021 - 01/2018
2	COVID-19 10/2020 - 01/2020
2	Inflammatory Breast Neoplasms 01/2017 - 08/2009
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2024
1	Hyperphosphatemia 11/2023
1	Hyperkalemia 11/2023
1	Hyperthyroidism 01/2023
1	Plasma Cell Neoplasms 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 09/2020
1	Thromboembolism 01/2019
1	Hypokalemia 01/2019
1	Sepsis (Septicemia) 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Diarrhea 01/2018
1	Nausea 01/2018

Drug/Important Bio-Agent (IBA)

17	Chimeric Antigen ReceptorsIBA 12/2023 - 12/2018
8	tisagenlecleucelIBA 01/2023 - 01/2019
7	fludarabineIBA 01/2023 - 03/2003
7	AntigensIBA 12/2021 - 02/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2003
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 03/2003
5	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 06/2005
4	brexucabtagene autoleucelIBA 01/2023 - 01/2021
4	axicabtagene ciloleucelIBA 01/2023 - 01/2020
4	AnthracyclinesIBA 09/2020 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2011
3	Sirolimus (Rapamycin)FDA Link 04/2024 - 04/2013
3	Methotrexate (Mexate)FDA LinkGeneric 04/2024 - 08/2005
3	Tacrolimus (Prograf)FDA LinkGeneric 04/2024 - 08/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 05/2004
3	Monoclonal AntibodiesIBA 12/2013 - 05/2006
2	Alemtuzumab (Campath)FDA Link 04/2024 - 01/2020
2	ElectrolytesIBA 11/2023 - 01/2018
2	AntibodiesIBA 01/2023 - 01/2015
2	NivolumabIBA 01/2023 - 01/2017
2	pembrolizumabIBA 01/2023 - 01/2023
2	LigandsIBA 01/2022 - 01/2015
2	CytokinesIBA 01/2021 - 03/2008
2	SteroidsIBA 10/2020 - 01/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 03/2003
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 03/2003
2	Rituximab (Mabthera)FDA Link 01/2019 - 03/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 03/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 02/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2011
2	Cancer VaccinesIBA 12/2013 - 06/2005
2	VaccinesIBA 12/2013 - 02/2004
2	Etoposide (VP 16)FDA LinkGeneric 06/2005 - 03/2003
2	Trastuzumab (Herceptin)FDA Link 10/2004 - 04/2003
2	Taxoids (Taxanes)IBA 10/2004 - 05/2004
1	Interleukin-2 (IL2)IBA 02/2024
1	Phosphorus (Red Phosphorus)IBA 11/2023
1	Nucleic AcidsIBA 11/2023
1	PotassiumIBA 11/2023
1	Uric Acid (Urate)IBA 11/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2023
1	cyclopropapyrroloindoleIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	selinexorIBA 01/2018

Therapy/Procedure

35	Therapeutics 02/2024 - 04/2003
31	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2003
19	Drug Therapy (Chemotherapy) 04/2024 - 03/2003
19	Stem Cell Transplantation 04/2024 - 02/2004
13	Transplantation 01/2023 - 03/2003
9	Immunotherapy 01/2022 - 01/2002
7	Cell Transplantation 01/2023 - 02/2009
3	Homologous Transplantation 01/2019 - 11/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2024 - 01/2020
2	Aftercare (After-Treatment) 12/2013 - 10/2004
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2005 - 04/2005